TIETOJA TÄSTÄ JAKSOSTA
In this episode of The Bioactive Nexus, Dr. Bill Clark and Dr. Gene Bruno lead a forward-looking panel discussion on one of the most important shifts in the supplement industry: the move from subjective claims to quantifiable credibility.
Joined by industry leaders Tim Ziegenfuss (clinicalresearch), Elan Sudberg (analytical testing), and Michael Anthonavage (formulation and manufacturing), the conversation explores how credibility is defined—and where it often breaks down—across the full product lifecycle.
The panel unpacks the growing gap between what productsclaim, what science supports, and what consumers believe, and examines whether emerging tools like AI can help bridge that divide. From clinical trial design and real-world evidence to ingredient identity, manufacturing consistency, and transparency, this episode provides a systems-level view of what it truly means for a product to be credible.
As the industry evolves, one theme becomes clear: the future of trust will not be built on louder claims—but on verifiable, transparent, and measurable evidence.
